Back to Stakeholders

ARQ National Psychotrauma Centre is a leading Dutch institute specializing in the treatment and research of complex psychotrauma and PTSD, with roots in addressing the psychological wounds of World War II since 1945 and now one of Europe's foremost psychotrauma centers. ARQ is one of nine European sites conducting MAPS-affiliated clinical trials of MDMA-assisted therapy for PTSD, and integrates medication-assisted approaches including MDMA and ketamine into its high-intensity trauma treatment programs in partnership with Leiden University Medical Center.

Academic Research

0 papers

Published Papers

0

Trial Involvement

1

Distinct Focus Topics

0

Latest Publication

Unknown

Clinical Care Delivery Snapshot

Health Systems & Hospitals

Provider Model

Health System / Hospital Program

Organization Status

Unknown

Psychedelic Services

Unknown

Service Coverage

Global

Service Profile

Care Settings

Hospital Outpatient

Payer Models

Unknown

Non-Psychedelic Service Mix

Unknown

Visit Provider

Care Delivery Notes

Backfilled profile for existing L2 clinical care delivery stakeholder.

Quick Facts

Type
Non-Profit
HQ
Netherlands
Website
Visit

Sponsored Trials

1